← Back to Patent Explorer
US4005099A Expired / Lapsed US ⏱️ 0.0 years remaining

1-[(Dimethylamino)-methyl]-6-aryl-4H-imidazo[1,5-a][1,4]benzodiazepines

Assignee: Pharmacia and Upjohn Co
•
Filing: 1975-11-21
•
Granted: 1977-01-25
•
Expires: 1995-11-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula III ##STR1## wherein R 1 is hydrogen or methyl; wherein R 2 is hydrogen, fluoro, chloro, bromo, trifluoromethyl, or nitro; and wherein Ar is phenyl, o-chlorophenyl, o-fluorophenyl, o,o-difluorophenyl, or 2-pyridyl, are produced by a two-step process. The compounds of formula III as well as their pharmacologically acceptable acid addition salts thereof are antidepressant agents possessing additionally antianxiety activity. Thus these compounds III are useful in the treatment of anxieties in mammals and birds, and also as anti-depressants in man.

Inventors

  • 👤 Martin Gall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:59
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/64; C07D243/00; C07D243/06; C07D243/10; C07D243/14; C07D243/16; C07D487/00; C07D487/02; C07D487/04

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 43 words
A compound of the formula III: ##STR6##wherein R 1 is hydrogen or methyl; wherein R 2 is hydrogen, fluoro, chloro, bromo, trifluoromethyl, or nitro; and wherein A r is phenyl, o-chlorophenyl, o-fluorophenyl, o,o-difluorophenyl, or 2-pyridyl, and the pharmacologically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 43 words
A compound of the formula III: ##STR6##wherein R 1 is hydrogen or methyl; wherein R 2 is hydrogen, fluoro, chloro, bromo, trifluoromethyl, or nitro; and wherein A r is phenyl, o-chlorophenyl, o-fluorophenyl, o,o-difluorophenyl, or 2-pyridyl, and the pharmacologically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 43 words
A compound according to claim 1, of the formula IIIA: ##STR7## wherein R 1 is hydrogen or methyl; wherein R' 2 is hydrogen, fluoro, chloro, or trifluoromethyl; wherein R 3 is hydrogen, chloro, or fluoro, and the pharmacologically acceptable acid addition salts thereof.
Claim 4
Dependent Claim 41 words
A compound according to claim 1, of the formula IIIB: ##STR8##wherein R 1 is hydrogen or methyl; wherein R" 2 is hydrogen, chloro, or fluoro; and wherein R' 3 is hydrogen or chloro and the pharmacologically acceptable acid addition salts thereof.
Claim 5
Dependent Claim 25 words
A compound according to claim 1, wherein A r is 2-pyridyl, R 1 is hydrogen, R 2 is 8-bromo, and the compound is therefore 8-bromo-1-[(dimethylamino)methyl]-6-(2-pyridyl)-4H-imidazo[1,5-a][1,4]benzodiazepine.
Claim 6
Dependent Claim 27 words
A compound according to claim 3, wherein R 1 is CH 3 , R" 2 is 8-chloro, R' 3 is o-chloro and the compound is therefore 8-chloro-1-[(dimethylamino)methyl]-6-(o-chlorophenyl)-3-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine.
Claim 7
Dependent Claim 24 words
A compound according to claim 3, wherein R 1 and R' 3 are hydrogen, R" 2 is 8-chloro, and the compound is therefore 8-chloro-1-[(dimethylamino)methyl]-6-phenyl4H-imidazo[1,5-a][1,4]benzodiazepine.
Claim 8
Dependent Claim 25 words
A compound according to claim 3, wherein R 1 is methyl, R" 2 is 8-chloro, R' 3 is hydrogen, and the compound is therefore 8-chloro-1-[(dimethylamino)methyl]-3-methyl-6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepine.
Claim 9
Dependent Claim 24 words
A compound according to claim 3, wherein R 1 and R' 3 are hydrogen, R" 2 is o-fluoro and the compound is therefore 8-fluoro-1-[(dimethylamino)methyl]-6-phenyl-4Himidazo[1,5-a][1,4]benzodiazepine.
Claim 10
Dependent Claim 25 words
A compound according to claim 3, wherein R 1 is methyl; R" 2 is 8-trifluoromethyl, R' 3 is hydrogen, and the compound is therefore 8-trifluoromethyl-1-[(dimethylamino)methyl]-3-methyl-6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepine.
Claim 11
Dependent Claim 25 words
A compound according to claim 3, wherein R 1 is hydrogen, R" 2 is 8-fluoro, R' 3 is o-fluoro; and the compound is therefore 8-fluoro-1-[(dimethylamino)methyl]-6-(o-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine.

References Cited (Backward Citations)

US3910946A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-01-25 1980-07-26 1981-01-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-01-25 1984-07-26 1985-01-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-01-25 1988-07-26 1989-01-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag